Press "Enter" to skip to content

New patent expiration for Bayer Hlthcare drug STIVARGA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Bayer Hlthcare drug STIVARGA

Annual Drug Patent Expirations for STIVARGA
Annual Drug Patent Expirations for STIVARGA

Stivarga is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for STIVARGA.

This drug has two hundred and sixty-two patent family members in fifty-eight countries.

The generic ingredient in STIVARGA is regorafenib. One supplier is listed for this compound. Additional details are available on the regorafenib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Bayer Hlthcare drug STIVARGA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions